{
}
UBS has downgraded JENOPTIK shares from "Buy" to "Neutral," slashing the price target from €30 to €20.50 due to significant challenges in its semiconductor business linked to key customer ASML. Analyst Olivier Calvet doubts the company will meet its 2026 sales target of €1.2 billion or achieve the desired operating margin of 21-22%. Following the announcement, JENOPTIK shares fell by 4.62% to €17.97 in XETRA trading.
UBS has downgraded JENOPTIK shares from "Buy" to "Neutral," slashing the price target from €30 to €20.50. Analyst Olivier Calvet cites significant challenges in the semiconductor sector, particularly with key customer ASML, leading to doubts about achieving the 2026 sales target of €1.2 billion and the expected operating margin of 21-22%. Following the announcement, JENOPTIK shares fell 6.05% to €17.70 in XETRA trading.
UBS has downgraded Jenoptik shares from "Buy" to "Neutral," lowering the price target from 30 to 20.50 euros. Analyst Olivier Calvet cites significant challenges in the semiconductor sector, particularly due to issues with key customer ASML, leading to doubts about achieving the 2026 sales target of EUR 1.2 billion and the expected operating margin of 21 to 22 percent. Investors are advised to exercise patience with the company.
UBS has downgraded Jenoptik's stock from "buy" to "neutral," lowering the price target from €30 to €20.50. Analyst Olivier Calvet cites significant challenges in the semiconductor sector, particularly due to major customer ASML, leading to skepticism about meeting the 2026 sales target of €1.2 billion and the operating margin goal of 21-22%. Investors may need to exercise patience with the well-managed company.
UBS has downgraded Jenoptik shares from "Buy" to "Neutral," lowering the price target from 30 euros to 20.50 euros. Analyst Olivier Calvet cites significant challenges in the semiconductor sector, particularly due to issues with key customer ASML, leading to doubts about achieving the 2026 sales target of 1.2 billion euros and the expected operating margin of 21 to 22 percent. Investors are advised to exercise patience with the company.
UBS has downgraded Jenoptik shares from "Buy" to "Neutral" and reduced the price target from €30 to €20.50, citing significant challenges in the semiconductor sector linked to key customer ASML. Analyst Olivier Calvet does not foresee the company meeting its 2026 sales goal of €1.2 billion or achieving the targeted operating margin of 21-22%. Investors are advised to exercise patience with the company.
UBS has maintained its "Buy" rating for Jenoptik, setting a price target of 30 euros following the company's 2024 business figures and outlook. Analyst Olivier Calvet noted that the consensus estimate for the operating margin (EBITDA) is at 20.7%, aligning with the upper end of Jenoptik's target range of 18 to 21 percent.
UBS has maintained its "Buy" rating for Jenoptik, setting a price target of 30 euros following the company's 2024 business figures and outlook. Analyst Olivier Calvet noted that the consensus estimate for the operating margin (EBITDA) of 20.7% is at the upper end of the company's target range of 18-21%.
UBS has maintained a "Buy" rating for Jenoptik, setting a price target of 29 euros following the mixed fourth quarter 2024 results. While the company surpassed sales and EBITDA expectations, incoming orders fell short, which may lead to cautious market reception.
UBS has maintained a "Buy" rating for Jenoptik, setting a price target of 29 euros following the mixed fourth quarter 2024 results. While the company surpassed consensus estimates in sales and EBITDA, incoming orders fell short of expectations, which may lead to cautious market reactions.
Jenoptik AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS downgrades Jenoptik shares amid semiconductor challenges and price target cut
14:25 03.04.2025
UBS downgrades JENOPTIK shares and cuts price target significantly
12:28 03.04.2025
ubs downgrades jenoptik to neutral with lowered price target of 20.50 euros
10:17 03.04.2025
ubs downgrades jenoptik to neutral with lowered price target of 20.50 euro
10:17 03.04.2025
UBS downgrades Jenoptik to neutral with target price cut to 20.50 euros
10:17 03.04.2025
ubs downgrades jenoptik shares and lowers price target significantly
10:11 03.04.2025
ubs maintains buy rating for jenoptik with price target of 30 euros
16:06 25.03.2025
UBS maintains buy rating for Jenoptik with 30 euro price target
13:27 25.03.2025
UBS maintains buy rating for Jenoptik with price target of 29 euros
13:25 12.02.2025
UBS maintains buy rating for Jenoptik with 29 euro price target
10:35 12.02.2025
Trending
Subcategory
Stock Market Updates
Corporate News
Finance Mergers & Acquisitions
Industry Trends
Hedge Funds & Private Equity
Global Trade Developments
Global Financial Events
Market Analysis and Predictions
Financial Scams and Security
Government Policies
Banking Regulations
Economic Sanctions
CEO Changes
Retail and Consumer Goods
Startups & Entrepreneurship
Industry Mergers & Acquisitions
International Relations
Central Bank Actions
Workplace Trends
Domestic Politics
Countries:
Companies:
JPMorgan Chase & Co.
Tesla, Inc.
The Goldman Sachs Group, Inc.
Wells Fargo & Company
Bank of America Corporation
Barclays PLC
Apple Inc.
Morgan Stanley
Citigroup Inc.
Berkshire Hathaway Inc.
Microsoft Corporation
SpaceXCoin USD
The Charles Schwab Corporation
AMERICAN EXPRESS
Amazon.com, Inc.
U.S. Bancorp
UBS Group AG
Banco Santander, S.A.
Deutsche Bank Money Market PP
Citizens, Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
British Pound Sterling
South Korean Won
Swiss Franc
United Arab Emirates Dirham
Canadian Dollar
Israeli New Shekel
Swedish Krona
Mexican Peso
New Taiwan Dollar
People: